Under the terms of the agreement, signed on February 16, 2021, Glow has exclusive rights to market, sell and distribute ArtemiC™ in Canada, U.S., Mexico and all Carribean countries as a food supplement. ArtemiC™ is a clinically tested food supplement (nutraceutical, dietary supplement, natural health product) containing four natural based ingredients consisting of Artemisinin, Curcumin, Boswellia serrata, and Vitamin C. The formulation uses Glow's MyCell™ delivery system technology to increase bioavailability and effectiveness of natural active ingredients. ArtemiC™ was a collaborative development effort with Glow's strategic partner, Swiss PharmaCan AG and MGC Pharma ("MGC"), and will be manufactured by MGC Pharma under EU-GMP.
- Forums
- ASX - By Stock
- RGT
- MGC Pharmaceuticals (ASX:MXC) appoints Nicole Godresse as Global Chief Sales Officer
MGC Pharmaceuticals (ASX:MXC) appoints Nicole Godresse as Global Chief Sales Officer, page-30
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.0¢ |
Change
0.010(3.13%) |
Mkt cap ! $15.97M |
Open | High | Low | Value | Volume |
32.0¢ | 34.0¢ | 32.0¢ | $1.401K | 4.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 375 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 375 | 0.275 |
1 | 15000 | 0.260 |
1 | 20000 | 0.250 |
1 | 2200 | 0.230 |
1 | 4545 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 11528 | 2 |
0.370 | 2000 | 1 |
0.380 | 1522 | 1 |
0.395 | 8746 | 1 |
0.400 | 1183 | 5 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |